2004
DOI: 10.1055/s-2004-831879
|View full text |Cite
|
Sign up to set email alerts
|

Severe Cardiotocographic Pathology at Labor: Effect of Acute Intravenous Tocolysis

Abstract: The purpose of this study was to evaluate the effect of acute tocolysis on severely pathological cardiotocographic (CTG) readings during the first stage of labor. Seventy-three consecutive parturients with full-term pregnancy were treated by acute tocolysis with a beta-mimetic agent after recognition of severe CTG abnormality in the first stage of labor. The main outcome measures were normalization or persistence of the CTG pattern after tocolysis. Risk factors with regard to CTG effect of tocolysis were also … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2005
2005
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 12 publications
0
1
0
1
Order By: Relevance
“…The 24-h interval between drug injections was based on the half-life of ritodrine hydrochloride; it was also selected to minimize the differences in the phase of intraamniotic inflammation. The MRA doses of 200 and 800 μg/min have been validated for use in short-term tocolysis to treat PTL and for use in acute tocolysis to treat intrauterine fetal distress, respectively [ 5 , 6 , 13 , 38 ]. As short-term MRA is recommended in clinical settings, and the duration of MRA to treat intrauterine fetal distress is clinically up to 2 hours, we comprehensively examined the effect of MRA for 2 h. The concentration of ritodrine hydrochloride in fetal serum was analyzed by liquid chromatography with tandem mass spectrometry (LC-MS/MS) [ 39 ] to confirm that fetal physiological changes were caused by MRA.…”
Section: Methodsmentioning
confidence: 99%
“…The 24-h interval between drug injections was based on the half-life of ritodrine hydrochloride; it was also selected to minimize the differences in the phase of intraamniotic inflammation. The MRA doses of 200 and 800 μg/min have been validated for use in short-term tocolysis to treat PTL and for use in acute tocolysis to treat intrauterine fetal distress, respectively [ 5 , 6 , 13 , 38 ]. As short-term MRA is recommended in clinical settings, and the duration of MRA to treat intrauterine fetal distress is clinically up to 2 hours, we comprehensively examined the effect of MRA for 2 h. The concentration of ritodrine hydrochloride in fetal serum was analyzed by liquid chromatography with tandem mass spectrometry (LC-MS/MS) [ 39 ] to confirm that fetal physiological changes were caused by MRA.…”
Section: Methodsmentioning
confidence: 99%
“…Dies gilt, obwohl es sich hierbei um ein Verfahren mit hoher Sensitivität handelt, welches nahezu sämtliche Fälle von kindlicher Gefährdung anzeigt, jedoch bei auffälliger kardiotokographischer Befundung in der Mehrzahl der Fälle für das Kind tatsächlich keine direkte Gefahr besteht. Es ist somit eine niedrige Spezifität der auffälligen kardiotokographische Befunde zu konstatieren [2, 4, 6,7,9,17,21,23,26,35,39].…”
Section: Introductionunclassified